THOMPSON PETER A. purchased 6.8% of their position (882.35K shares) of PREVAIL THERAPEUTICS INC. on the open market

Open‑market purchase worth $15.00M — a moderate purchase. The strongest form of insider conviction signal.

P · 1 purchase

THOMPSON PETER A.

Filed: 6/26/2019ACC: 0001209191-19-039130

InsiderTHOMPSON PETER A.CIK 1357522

→

IssuerPREVAIL THERAPEUTICS INC.CIK 1714798

Director10% Owner

Since Jun 2019

+882.35K

Net shares

Net buyer

$15.00M

Total acquired

Open market trades

1B · 0S

Total transactions

11.39M acquired · 10.51M disposed

Non-Derivative Transactions2

Common Stock

Indirect

C · Conversion

+10.51M

Price / share

—

Trade value

—

% of position

432.5%

6/24/2019

2.43M→12.94M

Common Stock

Indirect

P · Purchase

+882.35K

Price / share

$17.00

Trade value

$15M

% of position

6.8%

6/24/2019

12.94M→13.82M

Total

Net shares

+11.39M

Net value

$15M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Indirect	6/24/2019	C · Conversion	+10.51M	—	—	432.5%	2.43M	12.94M
Common Stock Indirect	6/24/2019	P · Purchase	+882.35K	$17.00	$15M	6.8%	12.94M	13.82M
Total			+11.39M		$15M

Derivative Transactions3

Series Seed Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

6.40M shares

−6.40M

Strike price

Held after

0.00

Exercisable

—

6/24/2019

Series A Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

3.10M shares

−3.10M

Strike price

Held after

0.00

Exercisable

—

6/24/2019

Series B Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

1.01M shares

−1.01M

Strike price

Held after

0.00

Exercisable

—

6/24/2019

Security	Converts To	Date	Type	Shares	Exercisable
Series Seed Preferred Stock Indirect	Common Stock6.40M shares	6/24/2019	C · Conversion	−6.40M	—
Series A Preferred Stock Indirect	Common Stock3.10M shares	6/24/2019	C · Conversion	−3.10M	—
Series B Preferred Stock Indirect	Common Stock1.01M shares	6/24/2019	C · Conversion	−1.01M	—